GlaxoSmithKline (GSK) EBITDA margin US GAAP (year values)

2022 2022 2022 2023 2023   LTM ? CAGR 5 years ?
EBITDA margin, % ? 30.0% 29.3% 30.0% 31.0% 29.9%   24.8%  
Changes by years, y/y, % +7pp -1pp +1pp +1pp -1pp     +4.6%

GlaxoSmithKline. EBITDA margin, %

Created with Highcharts 6.0.646.046.047.247.245.245.243.743.741.841.843.243.240.840.839.539.538.038.028.528.530.530.543.443.441.041.040.240.237.637.638.538.527.127.130.330.333.833.835.635.636.736.738.838.839.239.235.935.935.635.619.219.235.535.533.033.032.532.522.122.154.154.115.315.318.418.418.418.423.923.923.923.930.030.027.927.924.924.923.823.825.825.822.722.730.030.029.329.330.030.031.031.029.929.924.824.8198619871988198919901991199219931994199519951996199719981999200020012002200320032004200520062007200820092010201120122013201420152016201720172018201820192019202020202021202120222022202220232023LTM0102030405060smart-lab.ru

GlaxoSmithKline. EBITDA margin, changes, pp

Created with Highcharts 6.0.61.11.1-1.9-1.9-1.5-1.5-1.9-1.91.31.3-2.3-2.3-1.3-1.3-1.5-1.5-9.5-9.52.02.012.912.9-2.4-2.4-0.7-0.7-2.6-2.60.90.9-11.4-11.43.23.2-30.3-30.31.91.91.11.12.02.00.50.5-3.4-3.4-0.3-0.3-16.4-16.416.316.3-2.5-2.5-0.5-0.5-10.4-10.432.032.0-38.7-38.73.03.05.55.56.16.1-2.1-2.1-3.1-3.1-1.1-1.12.02.0-3.0-3.07.37.3-0.7-0.70.70.71.01.0-1.1-1.1-5.1-5.119871988198919901991199219931994199519951996199719981999200020012002200320032004200520062007200820092010201120122013201420152016201720172018201820192019202020202021202120222022202220232023LTM-60-40-2002040smart-lab.ru

GlaxoSmithKline (GSK) EBITDA margin US GAAP (quarter values)

2024Q2 2024Q1 2024Q3 2024Q2 2024Q3   LTM ?
EBITDA margin, % ? 36.2% 38.0% 14.6% 33.3% 14.6%   24.8%
Changes by years, y/y, % 0pp -2pp -24pp -3pp -24pp    
Changes by quarters, q/q, % +9pp +2pp -23pp +19pp -19pp    

GlaxoSmithKline. EBITDA margin, %

Created with Highcharts 6.0.6-51.7-51.7-175.4-175.4-147.6-147.6-150.5-150.524.924.953.853.818.418.433.733.726.926.928.028.034.734.738.138.137.437.422.822.837.037.039.539.535.235.229.129.137.537.536.836.837.937.930.730.742.442.438.338.342.042.029.529.544.644.639.639.640.940.928.328.340.940.939.439.436.836.827.127.136.036.035.135.137.837.833.833.834.634.67.17.136.836.8-1.5-1.541.441.433.133.137.237.230.430.434.534.529.829.829.129.138.338.332.532.530.130.135.135.132.332.328.628.626.826.819.919.913.913.9187.7187.718.818.819.019.01.91.919.719.74.94.920.820.815.315.325.625.613.813.830.730.73.13.121.321.313.313.328.928.926.326.333.233.228.128.127.127.117.217.223.623.620.020.026.926.940.540.540.540.525.525.527.027.030.130.130.130.118.318.312.912.935.935.925.025.025.025.027.727.727.727.725.725.725.725.739.539.536.636.639.539.536.636.631.331.336.636.614.414.438.538.534.434.427.727.727.727.736.236.238.038.014.614.633.333.314.614.61996Q21998Q22000Q12001Q12002Q12003Q12003Q12004Q12004Q12005Q12005Q12006Q12006Q12007Q12007Q12008Q12008Q12009Q12009Q12010Q12010Q12011Q12011Q12012Q12012Q12013Q12013Q12014Q12014Q12015Q12015Q12016Q12016Q12017Q12017Q12018Q12018Q12019Q12019Q12020Q12020Q12020Q22021Q22021Q12021Q22022Q22022Q32022Q42023Q12023Q12023Q32023Q42024Q12023Q42024Q12024Q2-200-1000100200300smart-lab.ru

GlaxoSmithKline. EBITDA margin, changes, pp

Created with Highcharts 6.0.6-123.8-123.827.827.8-2.9-2.9204.3204.3-6.5-6.5-20.1-20.18.68.6-5.6-5.67.77.710.010.010.510.5-5.3-5.3-0.4-0.416.716.7-2.3-2.36.36.32.32.37.77.72.72.71.61.64.54.57.77.74.14.1-1.2-1.22.62.610.110.1-1.1-1.1-1.1-1.1-0.0-0.011.111.1-4.1-4.1-1.2-1.2-0.9-0.98.08.01.01.06.76.7-3.2-3.2-26.7-26.7-1.0-1.0-35.3-35.34.64.634.634.60.40.431.931.9-2.8-2.8-0.6-0.6-8.1-8.17.87.83.43.4-8.2-8.25.95.9-6.0-6.0-6.4-6.4-5.5-5.5-15.2-15.2-18.4-18.4167.8167.84.94.9-0.9-0.9-12.0-12.00.70.73.13.11.81.813.413.44.94.9-1.5-1.59.99.9-12.2-12.2-9.4-9.410.110.1-1.8-1.823.223.24.34.31.71.7-1.8-1.8-9.1-9.1-3.5-3.52.82.8-0.2-0.223.323.3-1.4-1.4-13.6-13.63.23.2-27.6-27.65.85.812.112.112.112.13.63.611.611.63.63.611.611.63.63.611.611.6-11.3-11.310.810.8-5.2-5.22.02.02.02.0-0.4-0.4-1.6-1.6-23.9-23.9-3.3-3.3-23.9-23.91997Q21999Q22001Q12002Q12003Q12003Q12004Q12004Q12005Q12005Q12006Q12006Q12007Q12007Q12008Q12008Q12009Q12009Q12010Q12010Q12011Q12011Q12012Q12012Q12013Q12013Q12014Q12014Q12015Q12015Q12016Q12016Q12017Q12017Q12018Q12018Q12019Q12019Q12020Q12020Q12021Q12021Q12022Q12022Q22023Q22023Q22023Q22023Q32023Q42024Q22024Q32024Q3-1000100200-200300smart-lab.ru

GlaxoSmithKline. EBITDA margin, changes, pp

Created with Highcharts 6.0.6-123.8-123.827.827.8-2.9-2.9175.4175.428.928.9-35.4-35.415.315.3-6.8-6.81.11.16.66.63.43.4-0.6-0.6-14.7-14.714.214.22.52.5-4.4-4.4-6.1-6.18.48.4-0.6-0.61.11.1-7.2-7.211.811.8-4.1-4.13.73.7-12.5-12.515.115.1-5.0-5.01.41.4-12.6-12.612.612.6-1.5-1.5-2.6-2.6-9.7-9.78.88.8-0.9-0.92.72.7-4.0-4.00.80.8-27.5-27.529.729.7-38.3-38.342.942.9-8.3-8.34.14.1-6.8-6.84.04.0-4.7-4.7-0.7-0.79.29.2-5.8-5.8-2.4-2.45.05.0-2.8-2.8-3.6-3.6-1.8-1.8-6.9-6.9-6.0-6.0173.8173.8-168.9-168.90.20.2-17.1-17.117.817.8-14.8-14.815.815.8-5.5-5.510.310.3-11.9-11.916.916.9-27.5-27.518.118.1-8.0-8.015.715.7-2.6-2.66.96.9-5.2-5.2-0.9-0.9-9.9-9.96.36.3-3.5-3.56.86.813.713.7-15.0-15.01.51.53.13.1-11.9-11.9-5.4-5.423.023.0-10.9-10.92.72.7-2.0-2.013.813.8-3.0-3.03.03.0-3.0-3.0-5.2-5.25.25.2-22.2-22.224.124.1-4.1-4.1-6.7-6.78.58.51.81.8-23.4-23.418.718.7-18.7-18.71997Q21999Q22000Q22001Q22002Q22003Q22003Q22004Q22004Q22005Q22005Q22006Q22006Q22007Q22007Q22008Q22008Q22009Q22009Q22010Q22010Q22011Q22011Q22012Q22012Q22013Q22013Q22014Q22014Q22015Q22015Q22016Q22016Q22017Q22017Q22018Q22018Q22019Q22019Q22020Q22020Q42021Q12021Q32021Q42022Q12022Q22022Q32022Q42023Q22023Q22023Q22023Q32023Q42024Q22024Q32024Q3-200-1000100200smart-lab.ru